Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kopran Limited ( (IN:KOPRAN) ) has shared an announcement.
Kopran Limited has announced changes in its Board of Directors, with Mr. Siddhan Subramanian and Mrs. Sunita Banerji completing their terms as Non-Executive Independent Directors as of September 17, 2025. This change reflects the company’s adherence to regulatory requirements and may impact its governance structure, potentially influencing stakeholder confidence.
More about Kopran Limited
Kopran Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of pharmaceutical products. The company is based in Mumbai, India, and has a manufacturing facility in Raigad.
Average Trading Volume: 22,182
Technical Sentiment Signal: Hold
Current Market Cap: 8.51B INR
Learn more about KOPRAN stock on TipRanks’ Stock Analysis page.